Increases in PAI-1 expression have been reported in relation with neurovascular and cardiovascular diseases [59–61], as well as in neurodegenerative disorders, especially Alzheimer’s disease [62], during which NVC is dramatically affected [63–65]. Here, SERPINE1 is linked to early-onset autosomal dominant Alzheimer disease.